Pneumoconiosis laboratory findings: Difference between revisions
No edit summary |
|||
Line 43: | Line 43: | ||
OR | OR | ||
Some patients with | Some patients with pneumoconiosis may have elevated concentrations of some serum and urinary markers. These include SMRP, fibulin-3 which suggest asbestos exposure. Research is also in the development of a breath test to test for pneumoconiosis which would check the levels of pentane, C5-C7 alkanes, and methylated alkanes. <ref name="pmid32310362">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume= | issue= | pages= | pmid=32310362 | doi= | pmc= | url= }} </ref> <ref name="pmid30955520">{{cite journal| author=Perlman DM, Maier LA| title=Occupational Lung Disease. | journal=Med Clin North Am | year= 2019 | volume= 103 | issue= 3 | pages= 535-548 | pmid=30955520 | doi=10.1016/j.mcna.2018.12.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30955520 }} </ref> <ref name="pmid30946771">{{cite journal| author=Yang HY| title=Prediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals. | journal=PLoS One | year= 2019 | volume= 14 | issue= 4 | pages= e0214808 | pmid=30946771 | doi=10.1371/journal.pone.0214808 | pmc=6448873 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30946771 }} </ref> | ||
==References== | ==References== |
Revision as of 22:47, 26 April 2021
Pneumoconiosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pneumoconiosis laboratory findings On the Web |
American Roentgen Ray Society Images of Pneumoconiosis laboratory findings |
Risk calculators and risk factors for Pneumoconiosis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD
Overview
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
OR
Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
OR
[Test] is usually normal for patients with [disease name].
OR
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
OR
There are no diagnostic laboratory findings associated with [disease name].
Laboratory Findings
There are no diagnostic laboratory findings associated with [disease name].
OR
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
OR
[Test] is usually normal among patients with [disease name].
OR
Laboratory findings consistent with the diagnosis of [disease name] include:
- [Abnormal test 1]
- [Abnormal test 2]
- [Abnormal test 3]
OR
Some patients with pneumoconiosis may have elevated concentrations of some serum and urinary markers. These include SMRP, fibulin-3 which suggest asbestos exposure. Research is also in the development of a breath test to test for pneumoconiosis which would check the levels of pentane, C5-C7 alkanes, and methylated alkanes. [1] [2] [3]
References
- ↑ "StatPearls". 2021. PMID 32310362 Check
|pmid=
value (help). - ↑ Perlman DM, Maier LA (2019). "Occupational Lung Disease". Med Clin North Am. 103 (3): 535–548. doi:10.1016/j.mcna.2018.12.012. PMID 30955520.
- ↑ Yang HY (2019). "Prediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals". PLoS One. 14 (4): e0214808. doi:10.1371/journal.pone.0214808. PMC 6448873. PMID 30946771.